, Chien-Chuan Chen3
, Ping-Huei Tseng3,4
1Division of Gastroenterology and Hepatology, Department of Internal Medicine, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi, Taiwan
2Obesity Center, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi, Taiwan
3Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
4Division of Endoscopy, Department of Integrated Diagnostics and Therapeutics, National Taiwan University Hospital, Taipei, Taiwan
© 2026 Korean Society of Gastrointestinal Endoscopy
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Conflicts of Interest
Ping-Huei Tseng is an associate editor of Clinical Endoscopy but had no role in the peer reviewer selection, manuscript evaluation, or editorial decision related to this article.
Funding
This study was supported by research grants from the National Taiwan University Hospital (NTUH 114-S0250) and Ministry of Science and Technology (MOST 111–2314-B-002–189-MY3).
Author Contributions
Conceptualization: CKC, PHT; Data curation: CKC, CCC; Formal analysis: CKC; Investigation: CKC, CCC; Methodology: CKC, PHT; Supervision: PHT; Writing–original draft: CKC; Writing–review & editing: all authors.
ESGE, European Society of Gastrointestinal Endoscopy; PPI, proton pump inhibitor; RCT, randomized controlled trial; ACG, American College of Gastroenterology; GERD, gastroesophageal reflux disease; AGA, American Gastroenterological Association; SAGES, Society of American Gastrointestinal and Endoscopic Surgeons; ASGE, American Society for Gastrointestinal Endoscopy; HH, hiatal hernia.
| Category | Procedure | Mechanism of action | Key technical features |
|---|---|---|---|
| Mucosal remodeling (ARMI) | ARMS | Resection induces cicatrization and scar formation to tighten the cardia and EGJ opening. | Involves semi-circumferential mucosal resection using EMR. |
| ARMA | Coagulation induces ulceration and subsequent fibrosis/shrinkage to remodel the EGJ barrier. | Uses thermal ablation (e.g., argon plasma coagulation) without tissue resection; technically less demanding than ARMS. | |
| Neuromodulation | Stretta | Delivers radiofrequency energy to the LES to induce submucosal fibrosis and potentially increase LES pressure and neuromodulation. | Uses a balloon catheter with four nitinol needle electrodes. |
| Endoscopic fundoplication | TIF | Mechanically reconstructs the GEFV and steepens the Angle of His. | Creates full-thickness plications (esophagogastric wrap) secured with polypropylene T-fasteners using the EsophyX device. |
| Society (year) | Transoral incisionless fundoplication | Radiofrequency therapy | Anti-reflux mucosal interventions |
|---|---|---|---|
| ESGE (2020) | Conditional recommendation: advised against widespread use; suggested only for highly selected patients (mild/no esophagitis, small/no hiatal hernia) to reduce PPI use. | Conditional recommendation: may be considered for symptom relief in selected patients without erosive esophagitis or hiatal hernia. | Suggest against routine use: due to limited data and potential risks, requires more RCTs. |
| ACG (2022) | Conditional recommendation: suggests use for carefully selected patients with proven GERD, regurgitation, and no hiatal hernia >2 cm or severe esophagitis. | Cannot recommend: cites inconsistent efficacy, variable outcomes, and limited objective improvement. | Not recommended/mentioned: insufficient evidence to support use. |
| AGA (2022) | Consider for routine practice: the only endoscopic procedure with sufficient evidence for selected patients (regurgitation predominant, minimal anatomical disruption). | Not recommended: does not include Stretta among recommended options; favors surgical or endoscopic fundoplication. | Not recommended: roles are not well-defined or endorsed. |
| SAGES (2023) | Established option: recognized as the most established endoscopic therapy; superior to medical therapy for symptoms but less durable than surgery. | Selected patients only: may offer symptomatic benefit but lacks durable objective reflux control; low certainty of evidence. | N/A: not explicitly endorsed as a standard option compared to fundoplication. |
| ASGE (2025) | Conditional recommendation: a reasonable alternative for patients with confirmed GERD (HH ≤2 cm) who are unsuitable for or decline surgery. | Fallback option: suggested only when surgical or endoscopic fundoplication is not feasible; based on very low-quality evidence. | Investigational: use remains limited by technique heterogeneity and lack of robust randomized evidence. |
ARMI, anti-reflux mucosal intervention; ARMS, anti-reflux mucosectomy; EGJ, esophagogastric junction; EMR, endoscopic mucosal resection; ARMA, anti-reflux mucosal ablation; LES, lower esophageal sphincter; TIF, transoral incisionless fundoplication; GEFV, gastroesophageal flap valve.
ESGE, European Society of Gastrointestinal Endoscopy; PPI, proton pump inhibitor; RCT, randomized controlled trial; ACG, American College of Gastroenterology; GERD, gastroesophageal reflux disease; AGA, American Gastroenterological Association; SAGES, Society of American Gastrointestinal and Endoscopic Surgeons; ASGE, American Society for Gastrointestinal Endoscopy; HH, hiatal hernia.
